… we believe that more and more lipid–mRNA nanoparticle formulations will enter the clinic in
… vitamin C lipid nanoparticle (VcLNP) and applied the VcLNP–mRNA formulation to engineer …

… clinical translation of lipid nanoparticle–mRNA formulations, … clinical studies of lipid
nanoparticle–mRNA therapeutics for … examples of lipid nanoparticle–mRNA formulations in clinical …

… sequence design and nucleotide modification choice, (2) Optimization of a LNP formulation
to encapsulate and deliver mRNA and (3) long-term storage. Each one of these phases …

… mRNA in a single lipidoid nanoparticle (LNP) formulation. We accommodated the distinct
molecular characteristics of mRNA and siRNA in a formulation … PEG-lipid. Surprisingly, the co-…

… (mRNA) strands encapsulated in lipid nanoparticles (LNPs). The efficacy of these mRNA
vaccines … This review outlines how different aspects of the current mRNA vaccine formulations …

… lipid or lipid-like material, phospholipid, cholesterol, and lipid-… on the formulation potency.
Here, we develop a generalized strategy to optimize lipid nanoparticle formulations for mRNA …

Lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to
be very successful in the fight against the coronavirus disease 2019 (COVID-19) pandemic. …

… Treatment of B16F10 melanoma tumors with lipid nanoparticles containing mRNA coding …
, the lipid nanoparticle formulation presented here is a promising vector for mRNA vaccine …

… LNP formulations with cationic and ionizable lipids with … We show that LNPs formulated
with cationic lipids protect saRNA … lipids based on their properties and previous use in mRNA …

… of mRNA-LNP products, including mRNA-1944 (an LNP formulation of two mRNAs encoding
… virus) [106], mRNA-3927 (an LNP formulation of two mRNAs encoding the alpha and beta …